Advertisement

Mögliche Techniken für eine Hämophilie-Gentherapie

  • R. Schwaab
  • J.-P. Faber
  • J. Oldenburg
  • H.-H. Brackmann
Conference paper

Zusammenfassung

Die Hämophilie wird durch teilweise funktionsunfähige oder nicht vorhandene Gerinnungsproteine ausgelöst. Ist das Faktor VIII-Protein defekt, liegt eine Hämophilie A vor. Ist dagegen das Faktor IX-Protein defekt, spricht man von einer Hämophilie B. Beide Erbkrankheiten werden durch Mutationen im Faktor VIII- bzw. Faktor IX-Gen ausgelöst [1, 2].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Tuddenham EGD, Cooper DN, Gitschier J et al (1991) Haemophilia: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene. Nucleic Acids Res 19: 4821–4833PubMedCrossRefGoogle Scholar
  2. 2.
    Gianelli F, Green PM, High KA et al (1993) Haemophilia B: database of point mutations and short additions and deletions-fourth edition, 1993. Nucleic Acids Res 21:3075–3087CrossRefGoogle Scholar
  3. 3.
    Gill JC (1993) Therapy of factor VIII deficiency. Semin Thromb Haemost 19: 1–12CrossRefGoogle Scholar
  4. 4.
    Limentani SA, Roth DA, Furie BC, Furie B (1993) Recombinant blood clotting proteins for hemophilia therapy. Semin Thromb Haemost 19: 62–72CrossRefGoogle Scholar
  5. 5.
    Friedmann T (1989) Progress toward human gene therapy. Science 244: 1275–1280PubMedCrossRefGoogle Scholar
  6. 6.
    Kaufman RJ (1992) Expression and structure-function properties of recombinat factor VIII. Transfusion Med Rev 4: 235–246CrossRefGoogle Scholar
  7. 7.
    Kurachi K, Furukawa M, Yao S-N, Kurachi S (1992) Biology of factor IX. Coagulation Disorders 1: 991–997Google Scholar
  8. 8.
    Miller D (1990) Retrovirus packaging cells. Human Gene Therapy 1: 5–14PubMedCrossRefGoogle Scholar
  9. 9.
    Raffaele HS (1993) Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID. Human Gene Therapy 4: 513–521CrossRefGoogle Scholar
  10. 10.
    Mulligan RC (1993) The basic science of gene therapy. Science 260: 926–932PubMedCrossRefGoogle Scholar
  11. 11.
    Kozarsky KF, Wilson JM (1993) Gene therapy: adenovirus vectors. Curr Opinion Genet Develop 3: 499–503CrossRefGoogle Scholar
  12. 12.
    Feigner PL, Rhodes G (1991) Gene therapeutics. Nature 349: 351–352CrossRefGoogle Scholar
  13. 13.
    Zabner J, Couture LA, Gregory RJ et al (1993) Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75: 207–216PubMedCrossRefGoogle Scholar
  14. 14.
    Brinkhous KM (1992) Gene transfer in the hemophilias: retrospect and prospect. Thromb Res 67: 329–338PubMedCrossRefGoogle Scholar
  15. 15.
    Kay MA, Baley P, Rothenberg S et al (1992) Expression of human alpha-1–antitrypsin in dogs after autologous transplantation of retroviraltransduced hepatocytes. Proc Natl Acad Sci USA 89: 89–93PubMedCrossRefGoogle Scholar
  16. 16.
    Anderson WF (1992) Human gene therapy. Science 256: 808–813PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • R. Schwaab
  • J.-P. Faber
  • J. Oldenburg
  • H.-H. Brackmann

There are no affiliations available

Personalised recommendations